LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
暂无分享,去创建一个
Min Chen | K. O’Connor | L. Towers | Kathleen L O 'connor | Chen M | Towers Ln | Kl O 'connor | Lpa | C. M | Chen M
暂无分享,去创建一个
Min Chen | K. O’Connor | L. Towers | Kathleen L O 'connor | Chen M | Towers Ln | Kl O 'connor | Lpa | C. M | Chen M